Cytoprotective doses of erythropoietin or carbamylated erythropoietin have markedly different procoagulant and vasoactive activities

Recombinant human erythropoietin (rhEPO) is receiving increasing attention as a potential therapy for prevention of injury and restoration of function in nonhematopoietic tissues. However, the minimum effective dose required to mimic and augment these normal paracrine functions of erythropoietin (EP...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς: Coleman, Thomas R., Westenfelder, Christof, Tögel, Florian E., Yang, Ying, Hu, Zhuma, Swenson, LeAnne, Leuvenink, Henri G. D., Ploeg, Rutger J., d’Uscio, Livius V., Katusic, Zvonimir S., Ghezzi, Pietro, Zanetti, Adriana, Kaushansky, Kenneth, Fox, Norma E., Cerami, Anthony, Brines, Michael
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: National Academy of Sciences 2006
Θέματα:
Biological Sciences
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC1458681/
https://ncbi.nlm.nih.gov/pubmed/16585502
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.0601377103
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια